Healthcare provider profile · identity verified

Kelsey Sicker, MD

Family Practice · HILLIARD, OH · NPI 1073072070

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	233	70
Levothyroxine Sodium	Levothyroxine Sodium	122	34
Amlodipine Besylate	Amlodipine Besylate	115	36
Gabapentin	Gabapentin	103	29
Omeprazole	Omeprazole	97	23
Lisinopril	Lisinopril	86	31
Losartan Potassium	Losartan Potassium	84	24
Furosemide	Furosemide	77	21
Metoprolol Tartrate	Metoprolol Tartrate	60	13
Hydrochlorothiazide	Hydrochlorothiazide	55	18
Escitalopram Oxalate	Escitalopram Oxalate	54	14
Rosuvastatin Calcium	Rosuvastatin Calcium	54	25
Carvedilol	Carvedilol	53	16
Metformin Hcl	Metformin Hcl	53	21
Ozempic	Semaglutide	52	suppressed
Metoprolol Succinate	Metoprolol Succinate	51	18
Trazodone Hcl	Trazodone Hcl	50	15
Albuterol Sulfate Hfa	Albuterol Sulfate	49	16
Eliquis	Apixaban	45	13
Sertraline Hcl	Sertraline Hcl	45	14
Metformin Hcl Er	Metformin Hcl	43	14
Pantoprazole Sodium	Pantoprazole Sodium	39	14
Tramadol Hcl	Tramadol Hcl	36	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	11
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Simvastatin	Simvastatin	32	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Meloxicam	Meloxicam	27	suppressed
Fluticasone Propionate	Fluticasone Propionate	26	12
Alendronate Sodium	Alendronate Sodium	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Jardiance	Empagliflozin	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Trulicity	Dulaglutide	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Famotidine	Famotidine	20	suppressed
Allopurinol	Allopurinol	19	suppressed
Glipizide	Glipizide	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Montelukast Sodium	Montelukast Sodium	18	suppressed
Prednisone	Prednisone	18	12
Pregabalin	Pregabalin	18	suppressed
Myrbetriq	Mirabegron	17	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Atenolol	Atenolol	16	suppressed
Clopidogrel	Clopidogrel Bisulfate	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Lactulose	Lactulose	13	suppressed
Naproxen	Naproxen	13	11
Nexium	Esomeprazole Magnesium	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Azithromycin	Azithromycin	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Finasteride	Finasteride	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Rexulti	Brexpiprazole	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error